1. Current issues of lipid-lowering and antithrombotic therapy

   • Valentin Fuster

   Editor’s Commentary Pages: 173 - 174

2. Web alert

   • Peter H. Jones

   OriginalPaper Pages: 175 - 176

3. Literature alert

   • Richard C. Becker

   OriginalPaper Pages: 177 - 178

4. Recent trials of antithrombotics in the management of patients with acute coronary syndromes

   • Robert A. Harrington

   Clinical Trials Review Pages: 181 - 183

5. Direct thrombin inhibitors as adjuncts to thrombolytic therapy

   • John K. French
   • Harvey D. White

   OriginalPaper Pages: 184 - 191

6. The thienopyridines in coronary artery disease

   • Peter B. Berger

   OriginalPaper Pages: 192 - 198

7. Platelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes

   • Koon Hou Mak
   • David J. Moliterno

   OriginalPaper Pages: 199 - 205

8. Low molecular weight heparin in acute coronary syndromes

   • Christopher P. Cannon

   OriginalPaper Pages: 206 - 211

9. Current state of thrombolytic therapy

   • David A. Vorchheimer

   OriginalPaper Pages: 212 - 220

10. Fibrates and high-dose statins to prevent coronary heart disease events

    • Peter H. Jones

    Clinical Trials Review Pages: 223 - 224

11. Non—Lipid-lowering effects of statins on atherosclerosis

    • Robert S. Rosenson

    OriginalPaper Pages: 225 - 232

12. Identification and treatment of hypertriglyceridemia as a risk factor for coronary heart disease

    • Henry N. Ginsberg

    OriginalPaper Pages: 233 - 237

13. Effect of lipid-lowering therapy on vasomotion and endothelial function

    • Scott Kinlay
    • Jorge Plutzky

    OriginalPaper Pages: 238 - 243

14. Combination drug therapy for combined hyperlipidemia

    • John R. Guyton

    OriginalPaper Pages: 244 - 250

15. Inflammation and lipid-lowering treatment

    • Christie M. Ballantyne
    • Yasunori Abe

    OriginalPaper Pages: 251 - 255